Michael Ryskin
Stock Analyst at B of A Securities
(1.52)
# 3,456
Out of 5,048 analysts
38
Total ratings
54.17%
Success rate
-0.93%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVTY Revvity | Maintains: Buy | $110 → $99 | $92.97 | +6.49% | 1 | Sep 22, 2025 | |
| TEM Tempus AI | Maintains: Neutral | $68 → $70 | $88.71 | -21.09% | 6 | Jun 25, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Neutral | $535 → $475 | $722.94 | -34.30% | 3 | Apr 21, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Buy | $9 → $8 | $2.94 | +172.11% | 3 | Mar 3, 2025 | |
| ALGN Align Technology | Maintains: Underperform | $200 → $206 | $138.53 | +48.70% | 6 | Dec 13, 2024 | |
| GH Guardant Health | Maintains: Buy | $28 → $40 | $98.92 | -59.56% | 1 | Jul 18, 2024 | |
| ALIT Alight | Maintains: Buy | $10 → $9.5 | $2.75 | +245.45% | 1 | Jun 25, 2024 | |
| CERT Certara | Maintains: Buy | $27 → $24 | $11.70 | +105.13% | 2 | Aug 15, 2023 | |
| AVTR Avantor | Maintains: Buy | $27 → $24 | $11.68 | +105.48% | 2 | Jul 31, 2023 | |
| ZTS Zoetis | Maintains: Buy | $225 → $180 | $144.35 | +24.70% | 7 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.44 | - | 2 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $80 → $52 | $20.55 | +153.04% | 2 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $17 → $10 | $4.11 | +143.31% | 2 | Nov 10, 2021 |
Revvity
Sep 22, 2025
Maintains: Buy
Price Target: $110 → $99
Current: $92.97
Upside: +6.49%
Tempus AI
Jun 25, 2025
Maintains: Neutral
Price Target: $68 → $70
Current: $88.71
Upside: -21.09%
IDEXX Laboratories
Apr 21, 2025
Maintains: Neutral
Price Target: $535 → $475
Current: $722.94
Upside: -34.30%
Maravai LifeSciences Holdings
Mar 3, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $2.94
Upside: +172.11%
Align Technology
Dec 13, 2024
Maintains: Underperform
Price Target: $200 → $206
Current: $138.53
Upside: +48.70%
Guardant Health
Jul 18, 2024
Maintains: Buy
Price Target: $28 → $40
Current: $98.92
Upside: -59.56%
Alight
Jun 25, 2024
Maintains: Buy
Price Target: $10 → $9.5
Current: $2.75
Upside: +245.45%
Certara
Aug 15, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $11.70
Upside: +105.13%
Avantor
Jul 31, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $11.68
Upside: +105.48%
Zoetis
Nov 4, 2022
Maintains: Buy
Price Target: $225 → $180
Current: $144.35
Upside: +24.70%
Apr 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $5.44
Upside: -
Nov 11, 2021
Downgrades: Neutral
Price Target: $80 → $52
Current: $20.55
Upside: +153.04%
Nov 10, 2021
Downgrades: Underperform
Price Target: $17 → $10
Current: $4.11
Upside: +143.31%